Drug intelligence / Profile preview

silver nanomix particles

Development stage
Preclinical
Lead developer
National Institute of Pharmaceutical Education and Research, Ahmedabad
Modality
Nanoparticles → Drug Delivery Systems
Administration
Topical
01

Overview

Silver nanomix particles are an innovative antimicrobial nanomaterial developed for wound healing and dressing applications. Created through a research collaboration between Bennet Pharmaceuticals and the National Institute of Pharmaceutical Education and Research, Ahmedabad (NIPER-A), the nanomaterial is formulated by systematically hybridizing metallic silver nanoparticles (AgNPs, sub-15 nm) with ionic silver (Ag+). This hybridization is designed to provide both immediate antibacterial activity (via the ionic silver component) and prolonged antibacterial activity (via the silver nanoparticle reserve). The formulation has demonstrated significantly higher antibacterial potential against pathogens such as *Escherichia coli*, *Staphylococcus aureus*, and *Pseudomonas aeruginosa* compared to conventional silver products and reference antibiotics, while offering dose compliance, toxicity reduction, and cost savings.

Other names
silver nanomix

Beyond the preview

Go deeper on silver nanomix particles.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on silver nanomix particles.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call